Endocarditis Clinical Trial
— ICE-COCAOfficial title:
Impact of Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Multicentric,Retrospective, Propensity-score Matching Study
Verified date | May 2020 |
Source | Gros, Alexandre, M.D. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Surgical delay in severe endocardits, with neurological complications, is still debated.
Early surgery, if indicated, permits to avoid new embolic events, or to fix valvular damages,
but can create or increase a cerebral hemorrage.
Hypothesis Cardiac surgery, as soon as possible, if indicated, would reduce mortality, in
severe left endocarditis, with neurological complications.
Primary objective To assess the impact of early versus late cardiac surgery on mortality at 1
year, in patients with severe endocarditis, with neurological complications.
Primary endpoint:
1) Mortality at 1 year
Secondary endpoints:
1. Analyze the factors associated with neurological degradation
2. Evaluate the neurological tolerance of cardiac surgery.
Status | Completed |
Enrollment | 192 |
Est. completion date | December 31, 2017 |
Est. primary completion date | August 18, 2010 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Left endocarditis - With indication of cardiac surgery - Severe endocaditis (SOFA score > or = 3/16) - With pre operative neurological complications Exclusion Criteria: - Age < 18 - Right endocarditis without left endocarditis - No severe endocarditis (SOFA score < 3) - Ne pre operative neurological complications - Endocarditis without indication of cardiac surgery |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Gros, Alexandre, M.D. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality | Death from any cause | at 1 year after the diagnosis of endocarditis | |
Secondary | Neurogical tolerance | Modified Rankin score after cardiac surgery, 0 (no symptoms at all) to 6 (death) | At 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05547607 -
Clinical and Diagnostic Features of Endocarditis
|
||
Completed |
NCT00750373 -
Early Surgery Versus Conventional Treatment in Infective Endocarditis
|
Phase 4 | |
Recruiting |
NCT03690076 -
Human Cardiac Mitochondria in Acute Endocarditis and Obesity
|
||
Terminated |
NCT01734694 -
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
|
Phase 4 | |
Terminated |
NCT00995384 -
Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis
|
N/A | |
Completed |
NCT04309591 -
Cytosorb Therapy in Cardiac Surgery
|
||
Recruiting |
NCT05142891 -
Renal Tolerance of Amoxicillin and Cloxacillin Combination
|
||
Recruiting |
NCT05703022 -
Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis.
|
N/A | |
Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
Completed |
NCT03377465 -
Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis
|
N/A | |
Recruiting |
NCT03892174 -
Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE)
|
N/A | |
Completed |
NCT03695861 -
Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves
|
N/A | |
Recruiting |
NCT02759978 -
Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
|
||
Completed |
NCT00709358 -
Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections
|
Phase 4 | |
Terminated |
NCT03148756 -
Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
|
Phase 2 | |
Enrolling by invitation |
NCT05156437 -
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
|
Phase 4 | |
Recruiting |
NCT06107309 -
Suppressive Antibiotic Therapy for Endocarditis
|
||
Completed |
NCT02251262 -
Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection
|
N/A | |
Recruiting |
NCT03112356 -
The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials
|
Phase 4 | |
Completed |
NCT01375257 -
Partial Oral Treatment of Endocarditis
|
Phase 4 |